Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery and validation of breast cancer subtypes

11 Sept 2006

Abstract excerpt

BACKGROUND: Previous studies demonstrated breast cancer tumor tissue samples could be classified into different subtypes based upon DNA microarray profiles. The most recent study presented evidence for the existence of five different subtypes: normal breast-like, basal, luminal A, luminal B, and ERBB2+. RESULTS: Based upon the analysis of 599 microarrays (five separate cDNA microarray datasets) using a novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Gene expression and cancer classification
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16965636
DOI: 10.1186/1471-2164-7-231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery and validation of breast cancer subtypesPMID 16965636Read ↗

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsSemantic proximity Read ↗

Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.Semantic proximity Read ↗

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.Semantic proximity Read ↗

The molecular portraits of breast tumors are conserved across microarray platforms.Semantic proximity Read ↗

Invasive Breast Cancer: Recognition of Molecular SubtypesSemantic proximity Read ↗

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor ExpressionSemantic proximity Read ↗

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profilingSemantic proximity Read ↗

Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast CancersSemantic proximity Read ↗

Identification and validation of an ERBB2 gene expression signature in breast cancersSemantic proximity Read ↗

Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancerSemantic proximity Read ↗

Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of OutcomeSemantic proximity Read ↗

Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.